The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
about
Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset.Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer's Disease Model Mice Targeting Beta-Amyloid Production.Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance.Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures.Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspectiveAβ42 pentamers/hexamers are the smallest detectable oligomers in solution.Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Why are Functional Amyloids Non-Toxic in Humans?Curcumin revitalizes Amyloid beta (25-35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2.APP/Aβ structural diversity and Alzheimer's disease pathogenesis.Small molecule-mediated inhibition of β-2-microglobulin-based amyloid fibril formation.Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells.Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review.Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model.Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain.Transglutaminases Derived from Astrocytes Accelerate Amyloid β Aggregation.Oleocanthal ameliorates amyloid-β oligomers' toxicity on astrocytes and neuronal cells: In vitro studies.Alzheimer's Disease, Oligomers, and Inflammation.An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease.A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicityCovalent labeling-mass spectrometry with non-specific reagents for studying protein structure and interactionsCharacterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation Studies
P2860
Q30835636-41F332E4-B4AA-4037-89E6-A4AEF87A34A4Q33603071-B3AB1F35-8884-4FDE-841A-4362AC91962FQ37525481-A4F3508D-C1EC-429F-AE68-3F5DBF3403EDQ37685356-E523C37C-A3F7-40FF-B47E-A76A8A8108FBQ38635996-C58C512B-BD8B-4CDD-AD0B-22C764C897ADQ38955638-119166DF-3D7A-46A8-9E2B-F403A8C2158EQ41044393-E34C2168-CEEB-4204-9E53-4066B319B653Q42237530-BDC7AD02-2F7F-4DF6-A6C2-F8ACFD041981Q46073648-26039808-1A79-49B3-9BE0-261F886D8FAAQ46251905-A6C54A04-0AAF-4231-98B5-64FF6FEEF800Q46302841-EDF44C48-598F-4929-88D9-C493024F8836Q46313432-B8E7447B-28F8-4653-8E04-26E98F04718CQ46320596-53788DD3-A2A4-4EC0-9EA4-4180157EBA8AQ46372407-BC20D9BF-E929-4465-97C2-6963AE98EF96Q47095504-F8D8F454-2BBA-4865-B0BC-536B3F55D537Q47110701-8607702A-C9D1-4391-B75C-00BD2EE53E9EQ47610324-ACFB7AF3-98CE-4FCB-84E5-80AA84BA7380Q47759823-D1D0758B-D666-435A-8B96-76F7F54518E6Q47833979-2E6AE202-52AD-4182-90D2-6B0F698B4F55Q48113629-479D85DE-BFE9-46CE-87BE-1A0DAB7548A6Q48175839-278A386D-3163-4734-AB88-AEAECD460902Q48227413-8318596F-D79A-43BD-9432-1A5B9818ED1EQ50740397-4451F0E2-2684-488B-815E-F4DF224E8D9CQ51065764-AAC6EA99-A5C0-4D91-88EE-56F6780DA0B3Q52644596-32EFA952-0347-49CE-9DDB-9D004E1E3469Q52653207-60809F75-982C-4ECC-AA6A-89654CCEA6D4Q53698735-1BF45104-B605-42C7-BA6D-835545A87FBDQ54977832-10ECD3ED-EF1D-4BEA-A959-E82EBFF1C4DAQ55365163-6C95AF9E-E3BB-449F-B6AA-715CE70E77FEQ55437462-F7E56AD0-C9C4-433E-92BF-599355079141Q57061905-E535913C-064E-4F0D-A8D8-188F9536B321Q57175988-2BE3ABE2-3104-4FEE-9F01-609A538089AEQ58696552-E4D67048-60BD-44C1-8F80-21F998801D10
P2860
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@ast
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@en
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@nl
type
label
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@ast
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@en
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@nl
prefLabel
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@ast
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@en
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@nl
P2093
P2860
P921
P3181
P1433
P1476
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
@en
P2093
Ashley N Nilson
Rakez Kayed
Urmi Sengupta
P2860
P3181
P356
10.1016/J.EBIOM.2016.03.035
P407
P5008
P577
2016-04-01T00:00:00Z